ARTICLE | Financial News
DMD play Exonics raises $40M series A
November 8, 2017 10:24 PM UTC
Exonics Therapeutics Inc. (Boston, Mass.) raised $40 million in a series A round from The Column Group. The company is developing its preclinical CRISPR technology to treat Duchenne muscular dystrophy.
The company launched in February with $5 million from CureDuchenne (see BioCentury, March 2)...
BCIQ Company Profiles